| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 9e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.097 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.075 | 0.2 |